Viracta Therapeutics (NASDAQ: VIRX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Viracta Therapeutics (NASDAQ: VIRX) through any online brokerage.
The latest price target for Viracta Therapeutics (NASDAQ: VIRX) was reported by HC Wainwright & Co. on Monday, May 3, 2021. The analyst firm set a price target for 35.00 expecting VIRX to rise to within 12 months (a possible 885.92% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Viracta Therapeutics (NASDAQ: VIRX) is $3.55 last updated June 29, 2022, 8:00 PM UTC.
There are no upcoming dividends for Viracta Therapeutics.
Viracta Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Viracta Therapeutics.
Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.